|
WuXi Biologics Completed Three Acquisitions to Enhance its Global Network
|
SHANGHAI, May 7, 2021 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a global company with leading open-access biologics technology platforms, announced that it has completed the acquisition...
Full "IntellAsia: Resources" article
|
|